Quality Control Reports

E-64 (trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane)

Cat# GL-ES-0033 CAS: 66701-25-5 C15H27N3O5

>=95%

E-64c (Loxistatin acid)

Cat# GL-ES-0034 CAS: 76684-89-4 C15H26N2O5

>=95%

E-64d (Aloxistatin)

Cat# GL-ES-0035 CAS: 88321-09-9 C17H30N2O5

>=95%

AEBSF hydrochloride

Cat# GL-ES-0036 CAS: 30827-99-7 C8H11ClFNO2S

>=97%

Aprotinin from bovine lung

Cat# GL-ES-0037 CAS: 9087-70-1 C284H432N84O79S7

>=90%

Bowman-Birk Inhibitor from soybean

Cat# GL-ES-0038 CAS: 37330-34-0 C354H525N97O113S14

>=85%

Soybean Trypsin Inhibitor (Kunitz)

Cat# GL-ES-0039 CAS: 9035-81-8 Protein

>=90%

PMSF (Phenylmethanesulfonyl fluoride)

Cat# GL-ES-0040 CAS: 329-98-6 C7H7FO2S

>=98.5%

N-Ethylmaleimide (NEM)

Cat# GL-ES-0041 CAS: 128-53-0 C6H7NO2

>=99%

Iodoacetamide

Cat# GL-ES-0042 CAS: 144-48-9 C2H4INO

>=99%

TLCK (N-alpha-Tosyl-L-lysine chloromethyl ketone HCl)

Cat# GL-ES-0043 CAS: 4272-74-6 C14H22Cl2N2O3S

>=95%

TPCK (N-Tosyl-L-phenylalanine chloromethyl ketone)

Cat# GL-ES-0044 CAS: 402-71-1 C17H18ClNO3S

>=95%

Kemptide (PKA substrate)

Cat# GL-ES-0045 CAS: 65189-71-1 C32H56N10O11

>=95%

Autocamtide-2 (CaMKII substrate)

Cat# GL-ES-0046 CAS: 149752-09-4 C56H95N17O22

>=95%

Crosstide (Akt substrate)

Cat# GL-ES-0047 CAS: 161363-96-2 C51H87N15O18

>=95%

Hippuryl-His-Leu (HHL, ACE substrate)

Cat# GL-ES-0048 CAS: 7764-50-3 C21H26N4O5

>=98%

Hippuryl-Gly-Gly

Cat# GL-ES-0049 CAS: 2489-15-6 C13H15N3O4

>=98%

Bz-Gly-His-Leu

Cat# GL-ES-0050 CAS: 6253-24-3 C21H28N4O5

>=98%

Bestatin

Cat# GL-PM-0001 CAS: 58970-76-6 C16H24N2O4

>=98%

Cilastatin sodium

Cat# GL-PM-0002 CAS: 81129-83-1 C16H25N2NaO5S

>=98%

Sacubitril

Cat# GL-PM-0003 CAS: 149709-62-6 C24H29NO5

>=98%

Aliskiren hemifumarate

Cat# GL-PM-0004 CAS: 173334-58-2 C33H53NO8·0.5C4H4O4

>=98%

Simeprevir

Cat# GL-PM-0005 CAS: 923604-59-5 C38H47N5O7S2

>=98%

Boceprevir

Cat# GL-PM-0006 CAS: 394730-60-0 C27H45N3O5

>=98%

Telaprevir

Cat# GL-PM-0007 CAS: 402957-28-2 C36H53N7O6

>=98%

Voxilaprevir

Cat# GL-PM-0008 CAS: 1535212-07-7 C40H52F4N6O9S

>=95%

Glecaprevir

Cat# GL-PM-0009 CAS: 1365970-03-1 C38H46F4N6O9S

>=95%

Paritaprevir

Cat# GL-PM-0010 CAS: 1216941-48-8 C40H43N7O7S

>=95%

Narlaprevir

Cat# GL-PM-0011 CAS: 920014-72-8 C30H47N3O6S

>=98%

Faldaprevir

Cat# GL-PM-0012 CAS: 874011-49-3 C40H49BrN6O9S

>=95%

Rupintrivir

Cat# GL-PM-0013 CAS: 223537-30-2 C25H35FN4O6

>=98%

RI-TAT (Retro-inverso TAT)

Cat# GL-PM-0014 CAS: Inquire C63H114N24O13

>=95%

RI-Penetratin (Retro-inverso)

Cat# GL-PM-0015 CAS: Inquire C100H152N34O19

>=95%

RI-BPC-157 (Retro-inverso)

Cat# GL-PM-0016 CAS: Inquire C62H98N16O22

>=95%

Sarcosine oligomer (Sar-Sar-Sar)

Cat# GL-PM-0017 CAS: Inquire C9H17N3O4

>=95%

Peptoid NMe-Ala-NMe-Leu-NMe-Phe

Cat# GL-PM-0018 CAS: Inquire C21H33N3O4

>=90%

Aza-Gly containing peptide (Aza-Gly-Leu-Phe-NH2)

Cat# GL-PM-0019 CAS: Inquire C16H24N4O3

>=90%

Aza-amino acid building block (Aza-Phe-OH)

Cat# GL-PM-0020 CAS: Inquire C9H10N2O3

>=95%

beta3-HAla-beta3-HVal-beta3-HLeu tripeptide

Cat# GL-PM-0021 CAS: Inquire C15H29N3O4

>=90%

Leupeptin hemisulfate

Cat# GL-PM-0022 CAS: 103476-89-7 C20H38N6O4·0.5H2SO4

>=90%

MG-132 (Z-Leu-Leu-Leu-CHO)

Cat# GL-PM-0023 CAS: 133407-82-6 C26H41N3O5

>=95%

MG-115 (Z-Leu-Leu-Nva-CHO)

Cat# GL-PM-0024 CAS: 133407-83-7 C25H39N3O5

>=95%

ALLN (Ac-Leu-Leu-Nle-CHO, Calpain Inhibitor I)

Cat# GL-PM-0025 CAS: 110044-82-1 C20H37N3O4

>=95%

PSI (Z-Ile-Glu(OtBu)-Ala-Leu-CHO)

Cat# GL-PM-0026 CAS: 150436-68-3 C33H53N4O8

>=95%

Bortezomib

Cat# GL-PM-0027 CAS: 179324-69-7 C19H25BN4O4

>=98%

Ixazomib citrate

Cat# GL-PM-0028 CAS: 1201902-80-8 C20H23BCl2N2O9

>=98%

Mu-Leu-HPhe-VSPh (Peptide vinyl sulfone)

Cat# GL-PM-0029 CAS: Inquire C28H39N3O5S

>=90%

TPCK (L-1-Tosylamido-2-phenylethyl chloromethyl ketone)

Cat# GL-PM-0030 CAS: 402-71-1 C17H18ClNO3S

>=95%

Fmoc-Ser(beta-D-GlcNAc(Ac)3)-OH

Cat# GL-SA-0001 CAS: 147254-52-0 C31H34N2O13

98.0%